Galmed Pharmaceuticals Ltd.
About Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2020
- $0
- Net income
- -$10.3M
- Total assets
- $18.6M
- Market cap
- $4.6M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $4.6M
- Shares outstanding
- 8.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 13, 2014
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $10.3M in FY2020.
- Trading 78% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Galmed Pharmaceuticals Ltd..
Write a review
News about Galmed Pharmaceuticals Ltd.
News & sentiment via Polygon.io
